Literature DB >> 16357227

The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C.

Shivendra Kishore1, Stefan Stamm.   

Abstract

The Prader-Willi syndrome is a congenital disease that is caused by the loss of paternal gene expression from a maternally imprinted region on chromosome 15. This region contains a small nucleolar RNA (snoRNA), HBII-52, that exhibits sequence complementarity to the alternatively spliced exon Vb of the serotonin receptor 5-HT(2C)R. We found that HBII-52 regulates alternative splicing of 5-HT(2C)R by binding to a silencing element in exon Vb. Prader-Willi syndrome patients do not express HBII-52. They have different 5-HT(2C)R messenger RNA (mRNA) isoforms than healthy individuals. Our results show that a snoRNA regulates the processing of an mRNA expressed from a gene located on a different chromosome, and the results indicate that a defect in pre-mRNA processing contributes to the Prader-Willi syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16357227     DOI: 10.1126/science.1118265

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  287 in total

1.  Hypothalamic expression of snoRNA Snord116 is consistent with a link to the hyperphagia and obesity symptoms of Prader-Willi syndrome.

Authors:  Qian Zhang; Gerrit J Bouma; Kristy McClellan; Stuart Tobet
Journal:  Int J Dev Neurosci       Date:  2012-06-01       Impact factor: 2.457

Review 2.  Common cellular and molecular mechanisms in obesity and drug addiction.

Authors:  Paul J Kenny
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

Review 3.  Non-coding RNAs in human disease.

Authors:  Manel Esteller
Journal:  Nat Rev Genet       Date:  2011-11-18       Impact factor: 53.242

Review 4.  Are snoRNAs and snoRNA host genes new players in cancer?

Authors:  Gwyn T Williams; Farzin Farzaneh
Journal:  Nat Rev Cancer       Date:  2012-01-19       Impact factor: 60.716

Review 5.  Regulation of alternative splicing by short non-coding nuclear RNAs.

Authors:  Amit Khanna; Stefan Stamm
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

6.  New horizons for selective 5-HT2C receptor ligands in psychiatric/neurological disorders.

Authors:  Sharon Rosenzweig-Lipson
Journal:  Neuropsychopharmacology       Date:  2011-01       Impact factor: 7.853

Review 7.  Diverse regulation of 3' splice site usage.

Authors:  Muhammad Sohail; Jiuyong Xie
Journal:  Cell Mol Life Sci       Date:  2015-09-14       Impact factor: 9.261

8.  The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome.

Authors:  Yonatan Stelzer; Ido Sagi; Ofra Yanuka; Rachel Eiges; Nissim Benvenisty
Journal:  Nat Genet       Date:  2014-05-11       Impact factor: 38.330

Review 9.  Structured non-coding RNAs and the RNP Renaissance.

Authors:  J Robert Hogg; Kathleen Collins
Journal:  Curr Opin Chem Biol       Date:  2008-10-23       Impact factor: 8.822

Review 10.  Non-coding RNAs and disease: the classical ncRNAs make a comeback.

Authors:  Rogerio Alves de Almeida; Marcin G Fraczek; Steven Parker; Daniela Delneri; Raymond T O'Keefe
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.